NCT07618741 Improving Outcomes After AF Ablation in Obese Patients
| NCT ID | NCT07618741 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Atrial Fibrillation (AF) |
| Study Type | INTERVENTIONAL |
| Enrollment | 520 participants |
| Start Date | 2021-09-16 |
| Primary Completion | 2030-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 520 participants in total. It began in 2021-09-16 with a primary completion date of 2030-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Improving Outcomes After AF Ablation in Obese Patients
Eligibility Criteria
Inclusion Criteria: * Patients with Class I indication of catheter ablation of paroxysmal or persistent AF and will undergo catheter ablation at National Taiwan University Hospital. Exclusion Criteria: 1. Informed consent could not be obtained due to personal problem 2. Unwillingness or inability to return for follow-up visits or reason to believe that adherence to follow-up visits wound be irregular 3. Current or scheduled enrollment in other conflicting studies, and 4. Concomitant disease or other medical condition likely to result in death within 6 months
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07618741 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Atrial Fibrillation (AF). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07618741 currently recruiting?
Yes, NCT07618741 is actively recruiting participants. Contact the research team at yenbin@ntu.edu.tw for enrollment information.
Where is the NCT07618741 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT07618741 clinical trial?
NCT07618741 is sponsored by National Taiwan University Hospital. The trial plans to enroll 520 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.